← Back to Clinical Trials
Recruiting NCT06650683

NCT06650683 Impact of Providing Nursing Support on Parental Stress Related to Preoperative Care of a Newborn with Hirschsprung's Disease

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06650683
Status Recruiting
Phase
Sponsor Assistance Publique Hopitaux De Marseille
Condition Hirschsprung Disease
Study Type INTERVENTIONAL
Enrollment 20 participants
Start Date 2023-08-14
Primary Completion 2025-08-13

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Pediatric HAH

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 20 participants in total. It began in 2023-08-14 with a primary completion date of 2025-08-13.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Impact of providing nursing support on parental stress related to preoperative care of a newborn with Hirschsprung's disease

Eligibility Criteria

Inclusion Criteria: * Families (one or two parents) with a newborn or infant under 2 months with confirmed or suspected Hirschsprung disease, for whom nursings are effective and performed 1 to 2 times a day while waiting for surgery. * With a possible return home before surgery * With an information leaflet and non-opposition form signed by one or both parent(s) or by the legal representative. Exclusion Criteria: * The absence of daily nursings * Initial ineffectiveness of nursings requiring a digestive stoma * Failure to return home before surgery * Refusal of one or both parent(s) or legal representative(s)

Contact & Investigator

Central Contact

Melanie Boulanger

✉ promotion.interne@ap-hm.fr

📞 +33491381245

Frequently Asked Questions

Who can join the NCT06650683 clinical trial?

This trial is open to participants of all sexes, studying Hirschsprung Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06650683 currently recruiting?

Yes, NCT06650683 is actively recruiting participants. Contact the research team at promotion.interne@ap-hm.fr for enrollment information.

Where is the NCT06650683 trial being conducted?

This trial is being conducted at Marseille, France.

Who is sponsoring the NCT06650683 clinical trial?

NCT06650683 is sponsored by Assistance Publique Hopitaux De Marseille. The trial plans to enroll 20 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology